Quick Answer
Zura Bio Ltd reported Net Income of -$68.65 million for fiscal year 2025.
Zura Bio Ltd — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Net Income | -$68.65M -31.0% |
-$52.40M +13.2% |
-$60.36M -134.5% |
-$25.74M | — |
| Diluted EPS | -$1.06 -76.7% |
-$0.60 +71.3% |
-$2.09 +98.5% |
-$141.97 | — |
| Total Assets | $113.95M -36.5% |
$179.53M +78.0% |
$100.84M +1816.4% |
$5.26M -96.3% |
$140.55M |
| Cash and Equivalents | $109.41M -38.0% |
$176.50M +76.8% |
$99.81M +723918.9% |
$13.8K -98.1% |
$729.2K |
| Stockholders Equity | $101.54M -30.8% |
$146.81M +147.5% |
$59.33M +285.1% |
-$32.06M | $0.00 |
| R&D Expense | $42.08M +72.5% |
$24.40M -44.5% |
$44.00M +85.7% |
$23.69M | — |
| Operating Income | -$75.25M -36.3% |
-$55.19M +11.9% |
-$62.64M -130.6% |
-$27.16M | — |
| Shares Outstanding | 73.68M +12.8% |
65.30M +49.8% |
43.59M +15484.8% |
279,720 | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$18.04M | +12.9% | -12.8% |
| Diluted EPS | September 30, 2025 | -$0.21 | +19.2% | -23.5% |
| Total Assets | September 30, 2025 | $143.94M | -23.9% | -8.8% |
| Cash and Equivalents | September 30, 2025 | $139.02M | -26.1% | -10.0% |
| Stockholders Equity | September 30, 2025 | $108.24M | -29.3% | -14.0% |
| R&D Expense | September 30, 2025 | $11.95M | +98.2% | +37.3% |
| Operating Income | September 30, 2025 | -$19.52M | -1.0% | -8.1% |
| Shares Outstanding | September 30, 2025 | 65.02M | -0.4% | +4.8% |
- Zura Bio Ltd reported Net Income of -$68.65 million for fiscal year 2025.
- Zura Bio Ltd showed a decrease of -31.0% in Net Income compared to the prior fiscal year.
- Zura Bio Ltd reported Diluted EPS of $1.06 per share (loss) for fiscal year 2025.
- Zura Bio Ltd showed a decrease of -76.7% in Diluted EPS compared to the prior fiscal year.
- Zura Bio Ltd reported Total Assets of $113.95 million for fiscal year 2025.
- Zura Bio Ltd showed a decrease of -36.5% in Total Assets compared to the prior fiscal year.
- Zura Bio Ltd reported Cash and Equivalents of $109.41 million for fiscal year 2025.
- Zura Bio Ltd showed a decrease of -38.0% in Cash and Equivalents compared to the prior fiscal year.
- Zura Bio Ltd reported Stockholders Equity of $101.54 million for fiscal year 2025.
- Zura Bio Ltd showed a decrease of -30.8% in Stockholders Equity compared to the prior fiscal year.
- Zura Bio Ltd reported R&D Expense of $42.08 million for fiscal year 2025.
- Zura Bio Ltd showed an increase of +72.5% in R&D Expense compared to the prior fiscal year.
- Zura Bio Ltd reported Operating Income of -$75.25 million for fiscal year 2025.
- Zura Bio Ltd showed a decrease of -36.3% in Operating Income compared to the prior fiscal year.
- Zura Bio Ltd reported Shares Outstanding of 73.68 million shares for fiscal year 2025.
- Zura Bio Ltd showed an increase of +12.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: